Stocks
Eli Lilly Surges Ahead in GLP-1 Market as Novo Faces 2026 Decline
While both giants face U.S. pricing squeezes on weight-loss drugs, Eli Lilly just forecasted massive 2026 growth while Novo Nordisk...
04/02/2026
3 views